Inicio・Lista de Acciones・Medpace Holdings Inc

Medpace Holdings Inc

Cerrado

SectorSanidad

587.72 2.7

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

575.11

Máximo

589.66

Métricas clave
By Trading Economics
Ingresos	-2.5M 121M
Ventas	727K 707M
P/B Media del Sector	33.683 68.51
BPA	4.25
Margen de beneficios	17.158
Empleados	6,500
EBITDA	-21M 134M

Recomendaciones
By TipRanks
Recomendaciones	Neutral
Estimación a 12 Meses	+0.89% upside

Dividendos
By Acuity
Próximas Ganancias	21 oct 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	924M 16B
Apertura anterior	585.02
Cierre anterior	587.72

Medpace Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 ago 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 jul 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29 jul 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 jul 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 jul 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 jul 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 jul 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 jul 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Comparación entre iguales

Cambio de precio

Medpace Holdings Inc previsión

Precio Objetivo

By TipRanks

0.89% repunte

Estimación a 12 Meses

Media 580.2 USD 0.89%

Máximo 692 USD

Mínimo 450 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medpace Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

11 ratings

Comprar

Mantener

Vender

De acuerdo con 11 analistas que ofrecen calificaciones bursátiles a para Medpace Holdings Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.